America

2024

Base

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noreferrer noopener" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div> 
<p class="has-drop-cap">Colgate-Palmolive Co. (NYSE: CL) has reported a robust performance for the <a href="https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-2nd-quarter-2024-results" target="_blank" aria-label="second quarter of 2024 (opens in a new tab)" rel="noreferrer noopener nofollow" class="deco-link">second quarter of 2024</a>, showcasing solid growth across various metrics. Net sales for the quarter reached $5.058 billion, reflecting a 4.9% increase from the previous year’s $4.822 billion. <br><br>Organic sales grew by an impressive 9.0%, driven by a balanced mix of volume growth and higher pricing. The company also saw a significant rise in its gross profit margins, with GAAP gross profit margin expanding by 280 basis points to 60.6%, and Base Business gross profit margin increasing by 300 basis points to 60.8%.</p> 
<p>In terms of earnings, Colgate-Palmolive reported a GAAP <a href="https://tokenist.com/investing/how-to-value-a-stock/" rel="dofollow" class="deco-link">EPS</a> of $0.89, marking a 48% increase from the $0.60 recorded in the same quarter last year. The adjusted EPS also saw an 18% rise, reaching $0.91 compared to $0.77 in the previous year. <br><br>The company’s net cash provided by operations for the first six months of 2024 was $1.671 billion. Colgate-Palmolive maintained its leadership in the oral care market, holding a global market share of 41.5% in toothpaste and 32.2% in manual toothbrushes.</p> 
<h3 id="colgate-palmolive-exceeds-analyst-expectations-in-q2">Colgate-Palmolive Exceeds Analyst Expectations in Q2</h3> 
<p>When comparing the current performance against market expectations, Colgate-Palmolive exceeded analysts’ predictions. <br><br>The market had anticipated an EPS of $0.86 and revenue of $5.01 billion for the quarter. However, the company reported an EPS of $0.89 and revenue of $5.058 billion, surpassing both metrics. This outperformance can be attributed to strong organic sales growth and effective pricing strategies.</p> 
<p>The company’s organic sales growth of 9.0% significantly outstripped the expectations, which were in the range of 5% to 7%. Colgate-Palmolive’s ability to deliver higher-than-expected earnings and sales highlights its operational efficiency and market strength. The increase in advertising investment by 18% during the quarter also indicates the company’s commitment to sustaining long-term growth.</p> 
<div class="cta-referral"> 
 <img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async"> 
 <div class="cta-referral__text"> 
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noreferrer noopener nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p> 
 </div> 
</div> 
<h3 id="guidance">Guidance</h3> 
<p>Looking ahead, Colgate-Palmolive has updated its financial guidance for the full year 2024. The company now expects net sales growth of 2% to 5%, accounting for a mid-single-digit negative impact from foreign exchange. <br><br>The guidance for organic sales growth has been raised to 6% to 8%, up from the previous 5% to 7%. This optimistic outlook is based on the company’s strong performance in the first half of the year and its strategic initiatives aimed at driving growth.</p> 
<p>On a GAAP basis, Colgate-Palmolive continues to anticipate gross profit margin expansion, increased advertising investment, and double-digit earnings per share growth. For its Base Business, the company has increased its earnings per share growth guidance to 8% to 11%, up from the prior mid to high-single-digit range. This revised guidance reflects the company’s confidence in its ability to sustain its growth momentum.</p> 
<p>The divisional performance for the second quarter also paints a positive picture. North America saw a 2.5% increase in net and organic sales, while Latin America reported a remarkable 7.6% rise in net sales and an 18.8% surge in organic sales. Europe, Asia Pacific, and Africa/Eurasia also posted solid growth, contributing to the overall positive performance. <br><br>Hill’s Pet Nutrition division, which represents 22% of the total company sales, reported a 5.5% increase in net sales and a 6.1% rise in organic sales.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe> 
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p> 
<h3 id="br"><br></h3> 
<p>The post <a rel="nofollow" href="https://tokenist.com/colgate-palmolive-exceeds-market-expectations-with-0-91-eps/">Colgate-Palmolive Exceeds Q2 Market Expectations with $0.91 EPS</a> appeared first on <a rel="nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Colgate-Palmolive Exceeds Q2 Market Expectations with $0.91 EPS

Зміст

Tokenist

Інші статті, опубліковані 26 лип. 2024 р.

Status (SNT) Price Prediction 2025, 2026, 2027, 2028, 2029 and 2030

Bitcoin Exceeds $67,000 as MTGOX Holdings Drop

‘We have to get rid of the folks who are in the way’ — Senators speak at Bitcoin 2024

Senators Lummis and Scott Discuss Bitcoin’s Future at Nashville

Bitcoin Jumps to $67,000 Under Trump’s Shadow

VanEck CEO says Bitcoin accounts for ‘way over 30%’ of his portfolio

Приєднуйтеся до нашої безкоштовної розсилки для отримання щоденних оновлень щодо крипто!